959162-99-3

Basic information

• Product Name: 6-chloro-4-(ethylamino)-3-Pyridinemethanol
• Synonyms: 6-chloro-4-(ethylamino)-3-Pyridinemethanol;(6-chloro-4-(ethylamino)pyridin-3-yl)methanol
• CAS NO: 959162-99-3
• Molecular Formula: C8H11ClN2O
• Molecular Weight: 186.63874
• Mol File: 959162-99-3.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 6-chloro-4-(ethylamino)-3-Pyridinemethanol(CAS DataBase Reference)
• NIST Chemistry Reference: 6-chloro-4-(ethylamino)-3-Pyridinemethanol(959162-99-3)
• EPA Substance Registry System: 6-chloro-4-(ethylamino)-3-Pyridinemethanol(959162-99-3)

Safety Data

• Hazardous Substances Data: 959162-99-3(Hazardous Substances Data)

Usage

General Description

6-chloro-4-(ethylamino)-3-pyridinemethanol is a chemical compound with a molecular structure containing a chloro, ethylamino, and pyridine groups. It is often used as an intermediate in the synthesis of pharmaceuticals and other organic compounds. The compound is typically synthesized through multi-step reaction processes, involving the conversion of 6-chloro-3-pyridinemethanol to the final product by reacting it with ethylamine. This chemical may be used in pharmaceutical research and drug development due to its potential biological activity and its ability to interact with specific molecular targets. Additionally, it may also have applications in other industries such as agrochemicals, dyes, and pigments.

Upstream product

• 959162-97-1 6-chloro-4-ethylamino-nicotinic acid ethyl ester 
• 105-50-0 diethyl 1,3-acetonedicarboxylate 
• 6975-44-6 4,6-dihydroxynicotinic acid ethyl ester 
• 40296-46-6 ethyl 4,6-dichloronicotinate 

Downstream Products

• 959163-01-0 6-chloro-4-ethylamino-pyridine-3-carbaldehyde 
• 1442473-63-3 1-(4-chloro-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-(3-chloro-5-fluorophenyl)urea 
• 1442473-66-6 methyl (3-(2-chloro-4-fluoro-5-(3-phenylureido)phenyl)-1-ethyl-2-oxo-1,2-dihydro-1,6-naphthyridin-7-yl)carbamate 
• 1442473-68-8 N-(3-(2-chloro-4-fluoro-5-(3-phenylureido)phenyl)-1-ethyl-2-oxo-1,2-dihydro-1,6-naphthyridin-7-yl)-2-methoxyacetamide 
• 1442473-72-4 4-amino-2-(7-chloro-1-ethyl-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-5-fluorobenzonitrile 
• 1442473-73-5 4-amino-2-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-5-fluorobenzonitrile 
• 1442473-74-6 1-(4-cyano-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea 
• 1442470-54-3 3-(5-amino-2-chloro-4-fluorophenyl)-7-(2-(dimethylamino)ethylamino)-1-ethyl-1,6-naphthyridin-2(1H)-one 
• 1442473-77-9 N-(1-ethyl-3-(4-fluoro-5-(3-(3-fluorophenyl)ureido)-2-methylphenyl)-2-oxo-1,2-dihydro-1,6-naphthyridin-7-yl)acetamide 
• 1012879-41-2 3-(5-amino-2-chlorophenyl)-1-ethyl-7-(methylamino)-1,6-naphthyridin-2(1H)-one 
• 1442470-89-4 3-(3-amino-6-chloro-2-fluorophenyl)-1-ethyl-7-(methylamino)-1,6-naphthyridin-2(1H)-one 
• 1442470-88-3 3-(3-amino-6-chloro-2-fluorophenyl)-7-chloro-1-ethyl-1,6-naphthyridin-2(1H)-one 
• 1442473-65-5 1-(4-chloro-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-(3-fluoro-5-methylphenyl)urea 
• 1442473-64-4 1-(4-chloro-5-(1-ethyl-7-((4-methoxybenzyl)(methyl)amino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-(3-fluoro-5-methylphenyl)urea 

Relevant articles and documents

GEM-DISUBSTITUTED HETEROCYCLIC COMPOUNDS AND THEIR USE AS IDH INHIBITORS

The present invention relates to certain gem-disubstituted heterocyclic compounds, which modulate the activity of Isocitrate Dehydrogenase (IDH). The compounds of this invention are therefore useful in treating diseases caused by mutated IDH1 and/or mutat

HETEROCONDENSED PYRIDONES COMPOUNDS AND THEIR USE AS IDH INHIBITORS

The present invention relates to certain substituted heterocondensed pyridone analogues of formula (I) which modulate the activity of Isocitrate Dehydrogenase (IDH). The compounds of this invention are therefore useful in treating diseases caused by mutat

INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR

Described herein are inhibitors of FGFR-4, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions to inhibit the activity of FGFR-4.